
ACS Sensors, Journal Year: 2025, Volume and Issue: unknown
Published: April 9, 2025
Tuberculosis (TB) is a highly contagious bacterial infection that remains leading cause of death and persistent threat to global health. The spread TB exacerbated by the major limitations conventional diagnostic approaches, such as complex technicalities, high cost, low sensitivity. To address these challenges, recent research has focused on using electrochemiluminescence (ECL) an alternative detection strategy coupled biosensors. ECL biosensors leverage electrochemically generated chemiluminescence, converting electrical energy light, novel transduction mechanism for This unique approach offers several advantages, namely, wide linear dynamic ranges, improved device sensitivities, prompt response times sensitive early detection. Review comprehensive overview advancements in biosensor configurations, including amplification strategies, substrates, development luminophores coreactants tailored biomarker focus designs, biorecognition elements like immunosensors, DNA sensors, aptasensors, along with various immobilization strategies target specific biomarkers. A discussion spans trends over past decade, clinical relevance, sensitivity thresholds, limits. Furthermore, widely recognized biomarkers commonly detected commercial tests are discussed alongside markers that, while not exclusive TB, have demonstrated importance. aims highlight potential ECL-based effective means advance early, reliable, accessible approach.
Language: Английский